Please check your internet connection and try again.
# Ecospirin (Aspirin Enteric-Coated)
## Overview
Ecospirin is a brand name for enteric-coated aspirin. Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that irreversibly inhibits cyclooxygenase (COX) enzymes, leading to reduced prostaglandin and thromboxane synthesis. The enteric coating is designed to delay absorption until the drug reaches the small intestine, potentially reducing gastric irritation.
## Primary Indications
* **Pain and Inflammation:** For mild to moderate pain and inflammation associated with conditions like arthritis, musculoskeletal pain, and dysmenorrhea.
* **Cardiovascular Prophylaxis:** Low-dose aspirin (typically 75-100 mg daily) is used for secondary prevention of cardiovascular events (e.g., myocardial infarction, stroke) and for primary prevention in select high-risk individuals.
* **Rheumatic Fever Prophylaxis:** To prevent recurrence of acute rheumatic fever.
## Adult Dosing
* **Pain and Inflammation:**
* **Analgesic/Anti-inflammatory:** 325 mg to 650 mg orally every 4 to 6 hours as needed. Maximum daily dose generally not to exceed 4 grams.
* **Rheumatoid Arthritis/Osteoarthritis:** 325 mg to 650 mg orally every 4 to 6 hours, or higher doses up to 4-6 grams daily in divided doses, depending on patient response and tolerance. Higher doses require careful monitoring for toxicity.
* **Cardiovascular Prophylaxis:**
* **Secondary Prevention:** 75 mg to 100 mg orally once daily.
* **Primary Prevention:** Typically 75 mg to 100 mg orally once daily, individualized based on risk assessment. (Note: Current guidelines for primary prevention vary and should be consulted).
* **Rheumatic Fever Prophylaxis:**
* **Acute Rheumatic Fever:** 60 mg/kg/day in 4-5 divided doses.
* **Recurrence Prophylaxis:** 20-30 mg/kg/day as a single dose or divided doses.
* **Kawasaki Disease:** Dosing varies by phase of illness and is typically managed by specialists.
Dose for specific indications may vary based on local protocols and clinical judgment.
## Pediatric Dosing
* **Pain and Inflammation:** Aspirin is generally **not recommended** for pain or fever in children and adolescents due to the risk of Reye's syndrome.
* **Rheumatic Fever Prophylaxis:**
* **Acute Rheumatic Fever:** 60 mg/kg/day in 4-5 divided doses. Maximum 3.6 grams/day.
* **Recurrence Prophylaxis:** 20-30 mg/kg/day as a single dose or divided doses. Maximum 1 gram/day.
* **Kawasaki Disease:** Dosing varies by phase of illness and is typically managed by specialists. Aspirin 3-5 mg/kg/day for antiplatelet effect after IVIG, or 8-12 mg/kg/day for anti-inflammatory effect during the acute febrile phase (use with caution and specialist guidance).
## Dose Adjustments
* **Renal Impairment:** Use with caution. Dose reduction may be necessary in severe renal impairment.
* **Hepatic Impairment:** Use with caution.
* **Elderly:** Increased risk of adverse effects, particularly gastrointestinal bleeding and tinnitus. Lower doses and careful monitoring are recommended.
## Contraindications
* Hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* History of aspirin-induced asthma, urticaria, or allergic-type reactions.
* Active peptic ulcer disease or significant gastrointestinal bleeding.
* Children and adolescents with viral infections (e.g., influenza, varicella) due to the risk of Reye's syndrome.
* Severe hepatic or renal impairment.
* Late pregnancy (third trimester).
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, gastritis, ulceration, bleeding, perforation.
* **Hematologic:** Increased bleeding time, bruising, petechiae, epistaxis, prolonged hemorrhage.
* **Ototoxicity:** Tinnitus, hearing loss (often dose-related and reversible).
* **Allergic Reactions:** Urticaria, angioedema, bronchospasm (especially in aspirin-sensitive asthmatics).
* **Reye's Syndrome:** In children and adolescents with viral infections.
* **Other:** Dizziness, headache, confusion.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of gastrointestinal toxicity and bleeding.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** May reduce antihypertensive efficacy; increased risk of renal impairment.
* **Methotrexate:** Increased methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Decreased uricosuric effect.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding.
* **Alcohol:** Increased risk of gastrointestinal irritation and bleeding.
## Monitoring
* **Bleeding:** Monitor for signs of occult or overt bleeding (e.g., guaiac stool, bruising, hematuria).
* **Renal Function:** Monitor BUN, creatinine, especially in elderly patients or those with pre-existing renal disease.
* **Hepatic Function:** Monitor LFTs if indicated.
* **Signs of Salicylism:** Tinnitus, dizziness, headache, confusion, especially with higher doses.
* **Gastrointestinal Symptoms:** Monitor for dyspepsia, abdominal pain, or signs of bleeding.
## Clinical Pearls
* The enteric coating may delay absorption but does not eliminate the risk of gastrointestinal side effects.
* For acute cardiovascular event prevention, immediate-release aspirin is often preferred initially until the patient is stable, followed by maintenance with low-dose aspirin.
* Patients taking aspirin for cardiovascular prophylaxis should generally continue it without interruption unless advised by a physician.
* Discontinue aspirin at least 5-7 days before elective surgery to minimize bleeding risk.
* Aspirin's antiplatelet effect is irreversible and lasts for the life of the platelet (7-10 days).
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the current prescribing information and relevant clinical guidelines for complete and up-to-date details before making any clinical decisions.*
